Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Jackson Stocking"'
Autor:
Alex K. Shalek, Benjamin M. Kuter, Christopher Alvarez-Breckenridge, Mia Bertalan, Michael White, Kellie E. Kolb, Alexander Kaplan, Andrew W. Navia, Ugonma Chukwueke, Brian A. Shaw, Sanjay M. Prakadan, Daniel P. Cahill, Ivanna Bihun, Jeffrey W. Miller, Priscilla K. Brastianos, Scott L. Carter, Samuel Markson, Eudocia Q. Lee, Viktor A. Adalsteinsson, Naema Nayyar, Robert H. Klein, Denisse Rotem, Albert E. Kim, Marc H. Wadsworth, Nancy Wang, Jackson Stocking, Megha Subramanian, Joana L. Mora, Ryan J. Sullivan
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-1 (2021)
Autor:
Viktor A. Adalsteinsson, Jackson Stocking, Megha Subramanian, Alex K. Shalek, Samuel Markson, Ivanna Bihun, Joana L. Mora, Andrew W. Navia, Scott L. Carter, Priscilla K. Brastianos, Daniel P. Cahill, Nancy Wang, Eudocia Q. Lee, Christopher Alvarez-Breckenridge, Kellie E. Kolb, Sanjay M. Prakadan, Marc H. Wadsworth, Denisse Rotem, Jeffrey W. Miller, Ryan J. Sullivan, Robert H. Klein, Michael White, Benjamin M. Kuter, Alexander Kaplan, Ugonma Chukwueke, Albert E. Kim, Mia Bertalan, Brian A. Shaw, Naema Nayyar
Publikováno v:
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Leptomeningeal disease (LMD) is a devastating complication of solid tumor malignancies, with dire prognosis and no effective systemic treatment options. Over the past decade, the incidence of LMD has steadily increased due to therapeutics that have e
Autor:
Christopher Alvarez-Breckenridge, Mario L. Suvà, Aarushi Jain, Matthew Lastrapes, Arlene H. Sharpe, Bob S. Carter, Juliana M Larson, Christine Herbert, Swaminathan Kumar, Daniel P. Cahill, Elizabeth R. Gerstner, Kristen E. Pauken, Corey M. Gill, Priscilla K. Brastianos, William T. Curry, Michael White, Michael Davies, Husain Danish, Maria Martinez-Lage, Scott L. Carter, Osmaan Shahid, Matthew P. Frosch, Magali De Sauvage, Genevieve M. Boland, Jackson Stocking, Benjamin M. Kuter, Alexander Kaplan, Samuel Markson, Andrew W. Navia, Ashish Dahal, Benjamin Izar, Brian V. Nahed, Brian C. Miller, Ryan J. Sullivan, Naema Nayyar, Nancy Wang, McKenzie Shaw, Megha Subramanian, Matthew R. Strickland, Joana L. Mora, Dennie T. Frederick, Albert E. Kim, Mia Bertalan, Brian A. Shaw
Melanoma-derived brain metastases (MBM) represent an unmet clinical need due to central nervous system (CNS) progression as a frequent, end-stage site of disease. Immune checkpoint inhibition (ICI) represents a clinical opportunity against MBM; howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0483dd667ef7575db2e923007376e7ef
https://doi.org/10.1101/2021.08.25.456956
https://doi.org/10.1101/2021.08.25.456956
Autor:
Elizabeth R. Gerstner, Denisse Rotem, Jackson Stocking, Christopher Alvarez-Breckenridge, Scott L. Carter, Aarushi Jain, Viktor A. Adalsteinsson, Mohini Singh, Anita Giobbie-Hurder, Kevin S. Oh, Mia Bertalan, Albert H. Kim, Robert H. Klein, Brian A. Shaw, Gregory Gydush, Priscilla K. Brastianos, Justin Rhoades, Matthew Lastrapes, Samuel Markson, Megha Subramanian, Ryan J. Sullivan, Deepika Nagabhushan, Michael White, Joana L. Mora, Naema Nayyar, Benjamin M. Kuter, Alexander Kaplan, Maura Mahar, Daniel P. Cahill
Publikováno v:
JAMA Network Open
Key Points Question Can cell-free DNA analysis of cerebrospinal fluid provide additional diagnostic utility beyond cytologic assessment? Findings In this diagnostic study of 43 cerebrospinal fluid samples from 22 patients with leptomeningeal disease
Autor:
Jackson Stocking, Alexander Kaplan, Anita Giobbie-Hurder, Mia Bertalan, Christopher Alvarez-Breckenridge, Priscilla K. Brastianos, Daniel P. Cahill, Donald P. Lawrence, Corey M. Gill, Tracy T. Batchelor, Kevin S. Oh, Helen A. Shih, Naema Nayyar, Keith T. Flaherty, Ryan J. Sullivan
Publikováno v:
The Oncologist. 24:671-679
Background Immune checkpoint blockade has systemic efficacy in patients with metastatic melanoma, including those with brain metastases (MBMs). However, immunotherapy-induced intracranial tumoral inflammation can lead to neurologic compromise, requir
Autor:
Christopher Alvarez-Breckenridge, Samuel Markson, Jackson Stocking, Matt Lastrapes, Naema Nayyar, Maria Martinez-Lage, Mario Suva, Ryan Sullivan, Daniel P Cahill, Scott Carter, Priscilla Brastianos
Publikováno v:
Neurosurgery. 67
Autor:
Daniel P. Cahill, Naema Nayyar, Elizabeth R. Gerstner, Robert H. Klein, Anita Giobbie-Hurder, Jackson Stocking, Matthew Lastrapes, Viktor A. Adalsteinsson, Benjamin M. Kuter, Scott Carter, Denisse Rotam, Maura Mahar, Mohini Singh, Justin Rhoades, Aarushi Jain, Brian Shaw, Megha Subramanian, Greg Gydush, Mia Bertalan, Joana L. Mora, Samuel Markson, Alexander Kaplan, Deepika Nagabhushan, Priscilla K. Brastianos, Ryan J. Sullivan, Albert H. Kim, Kevin S. Oh, Michael White, Christopher Alvarez-Breckenridge
Publikováno v:
Neuro Oncol
Leptomeningeal disease is a devastating complication of cancer that is frequently underdiagnosed due to the low sensitivity of cerebrospinal fluid cytology, the current gold-standard diagnostic method. We performed genomic sequencing on cerebrospinal
Autor:
Matt Lastrapes, Jackson Stocking, Scott L. Carter, Daniel P. Cahill, Benjamin Izar, Priscilla K. Brastianos, Christopher Alvarez-Breckenridge, Naema Nayyar, Mia Bertalan, Alexander Kaplan, Samuel Markson, Mario L. Suvà, Maria Martinez-Lage Alvarez, Ryan J. Sullivan
Publikováno v:
Neuro Oncol
Immune checkpoint inhibitors (ICI) have revolutionized oncologic treatment for metastatic melanoma. With improved systemic control, there has been increasing prevalence of patients with brain metastases. Recent evidence has demonstrated intracranial
Publikováno v:
Neuro Oncol
Melanomas frequently spread to the brain, with up to 75% of patients developing brain metastases. Treatment of metastatic melanoma has been revolutionized by the advent of immune checkpoint inhibitors (ICI) targeting PD-1 and CTLA-4. However, respons
Publikováno v:
Neuro-oncology Advances
Up to 75% of patients with melanoma develop brain metastases. While immune checkpoint inhibitors (ICI) targeting PD-1 and CTLA4 have revolutionized the treatment of metastatic melanoma, responses within the immune-specialized microenvironment of the